文献速递肝病消化道肿瘤与早癌消化内镜

简化MRI用于肝细胞癌筛查的系统综述与荟萃分析

Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.
PubMed 文献 · J Hepatol · 2021-02-03

该系统综述与荟萃分析纳入15项研究(2807例患者,917例HCC),评估简化MRI(AMRI)筛查HCC的诊断准确性,汇总每患者敏感度86%、特异度94%,每病灶敏感度77%,不同AMRI方案性能相当,超声敏感度低于AMRI(53% vs 82%)。

要点

  • AMRI筛查HCC的每患者汇总敏感度86%、特异度94%。
  • AMRI对<2 cm HCC敏感度69%,低于≥2 cm的86%。
  • 非增强与增强AMRI诊断性能相当,超声敏感度低于AMRI。

核心结论

  • AMRI对HCC筛查具有高敏感度和特异度,不同AMRI方案诊断性能相当。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE和EMBASE数据库,最终纳入15项研究(3项前瞻性、12项回顾性),共2807例患者,其中917例为HCC。

主要发现

  • 每患者汇总敏感度为86%(95% CI 84-88%,I2 0%),特异度为94%(95% CI 91-96%,I2 83%)。
  • 每病灶汇总敏感度为77%(95% CI 74-81%,I2 8%)。
  • AMRI检测<2 cm HCC的敏感度为69%,低于≥2 cm的86%。
  • 非增强AMRI与增强AMRI的敏感度和特异度分别为86%和94% vs 87%和94%,性能相当。
  • 超声的敏感度为53%,低于AMRI的82%。

临床怎么用

  • 在高危人群中,AMRI可作为HCC筛查的潜在替代方案,尤其当超声敏感度不足时。

局限性

  • 纳入研究以回顾性为主(12/15),可能影响证据强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Biannual ultrasound has poor sensitivity for hepatocellular carcinoma (HCC) screening. MRI is accurate for the detection of HCC, but a complete MRI is not feasible as a screening tool. Abbreviated MRI (AMRI) is an acceptable alternative. The diagnostic performance of different AMRI protocols is not known. We performed a systematic review to determine the diagnostic accuracy of AMRI for HCC screening. METHODS: We searched the MEDLINE and EMBASE databases for studies reporting the diagnostic accuracy of AMRI for HCC screening. The pooled sensitivity and specificity of different AMRI protocols were calculated based on a random intercept logistic regression model. The diagnostic performance of AMRI was compared with ultrasound. Study quality was assessed using the QUADAS-2 tool. RESULTS: Of the 11,327 studies screened by titles, 15 studies (3 prospective and 12 retrospective: 2,807 patients, 917 with HCC) were included in the final analysis. The pooled per-patient sensitivity and specificity were 86% (95% CI 84-88%, I2 0%) and 94% (95% CI 91-96%, I2 83%), respectively. Pooled per-lesion sensitivity was 77% (95% CI 74-81%, I2 8%). There was no influence of study type, screening setting, reference standard, and presence and etiology of cirrhosis on the performance of AMRI. The sensitivity of AMRI for detection of HCC <2 cm was lower than that for HCC ≥2 cm (69% vs. 86%). The sensitivity and specificity of non-contrast AMRI were comparable to contrast-enhanced AMRI (86% and 94% vs. 87% and 94%, respectively). The diagnostic performance of different non-contrast AMRI and contrast-enhanced AMRI protocols was comparable. The sensitivity of ultrasound was lower than AMRI (53% vs. 82%). CONCLUSIONS: AMRI has high sensitivity and specificity for HCC screening. Different AMRI protocols have comparable diagnostic performance. LAY SUMMARY: Abbreviated MRI (AMRI) has been suggested as an alternative to ultrasound and complete MRI for hepatocellular carcinoma (HCC) screening. Our study results showed that AMRI has a high per-patient and per-lesion sensitivity for HCC. Although the sensitivity of AMRI for detection of HCC <2 cm is considerably lower than for HCC ≥2 cm, it is substantially higher than ultrasound, making it a potential alternative for HCC screening in high-risk populations.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Gupta P, Soundararajan R, Patel A, et al. Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis. J Hepatol. 2021. PMID: 33548385. doi:10.1016/j.jhep.2021.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。